Celanese (CE) Financials

$52.86 -1.65 (-3.03%)

Closing price 05/30/2025 03:59 PM Eastern

Extended Trading

$52.58 -0.28 (-0.53%)

As of 05/30/2025 06:57 PM Eastern

Annual Income Statements for Celanese

This table shows Celanese's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-1,522	1,960	1,894	1,890	1,985	852	1,207	843	900	304
Consolidated Net Income / (Loss)	-1,514	1,964	1,902	1,896	1,992	858	1,213	849	906	285
Net Income / (Loss) Continuing Operations	-1,506	1,973	1,910	1,918	2,004	864	1,218	862	908	287
Total Pre-Tax Income	-996	1,183	1,421	2,248	2,251	988	1,510	1,075	1,030	488
Total Operating Income	-697	1,687	1,378	1,946	664	834	1,334	858	934	326
Total Gross Profit	2,356	2,603	2,380	2,682	1,293	1,606	1,972	1,511	1,405	1,318
Total Revenue	10,280	10,940	9,673	8,537	5,655	6,297	7,155	6,140	5,389	5,674
Operating Revenue	10,280	10,940	9,673	8,537	5,655	6,297	7,155	6,140	5,389	5,674
Total Cost of Revenue	7,924	8,337	7,293	5,855	4,362	4,691	5,183	4,629	3,984	4,356
Operating Cost of Revenue	7,924	8,337	7,293	5,855	4,362	4,691	5,183	4,629	3,984	4,356
Total Operating Expenses	3,053	916	1,007	736	629	772	638	653	471	992
Selling, General & Admin Expense	1,030	1,075	824	633	482	483	546	496	378	506
Research & Development Expense	130	146	112	86	74	67	72	73	78	119
Amortization Expense	159	164	62	25	22	24	24	20	9.00	11
Other Operating Expenses / (Income)	-24	-32	1.00	-2.00	5.00	-7.00	-	-	1.00	-4.00
Other Special Charges / (Income)	1,758	-437	8.00	-6.00	46	205	-4.00	64	5.00	360
Total Other Income / (Expense), net	-299	-504	43	302	1,587	154	176	217	96	162
Interest Expense	676	727	405	100	109	119	126	122	126	119
Interest & Investment Income	357	267	422	301	1,674	301	356	293	265	289
Other Income / (Expense), net	20	-44	26	101	22	-28	-54	46	-43	-8.00
Income Tax Expense	510	-790	-489	330	247	124	292	213	122	201
Net Income / (Loss) Discontinued Operations	-8.00	-9.00	-8.00	-22	-12	-6.00	-5.00	-13	-2.00	-2.00
Net Income / (Loss) Attributable to Noncontrolling Interest	8.00	4.00	8.00	6.00	7.00	6.00	6.00	6.00	6.00	-19
Basic Earnings per Share	($13.93)	$18.01	$17.48	$16.99	$16.85	$6.88	$8.99	$6.11	$6.21	$2.02
Weighted Average Basic Shares Outstanding	109.27M	108.85M	108.38M	111.22M	117.82M	123.93M	134.31M	137.90M	144.94M	150.84M
Diluted Earnings per Share	($13.93)	$17.92	$17.34	$16.86	$16.75	$6.84	$8.91	$6.09	$6.18	$2.00
Weighted Average Diluted Shares Outstanding	109.27M	109.38M	109.24M	112.08M	118.48M	124.65M	135.42M	138.32M	145.67M	152.29M
Weighted Average Basic & Diluted Shares Outstanding	109.33M	217.81M	216.95M	216.06M	228.35M	119.56M	134.30M	138M	144.90M	150.50M

This table shows Celanese's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-21	-1,914	116	155	121	698	951	220	91	767	191
Consolidated Net Income / (Loss)	-17	-1,911	120	153	124	701	949	221	93	769	193
Net Income / (Loss) Continuing Operations	-12	-1,906	122	154	124	707	950	220	96	770	194
Total Pre-Tax Income	-3.00	-1,519	183	183	157	132	714	216	121	-70	321
Total Operating Income	168	-1,405	248	250	210	259	842	335	251	56	308
Total Gross Profit	476	539	622	641	554	613	673	686	631	384	546
Total Revenue	2,389	2,370	2,648	2,651	2,611	2,569	2,723	2,795	2,853	2,348	2,301
Operating Revenue	2,389	2,370	2,648	2,651	2,611	2,569	2,723	2,795	2,853	2,348	2,301
Total Cost of Revenue	1,913	1,831	2,026	2,010	2,057	1,956	2,050	2,109	2,222	1,964	1,755
Operating Cost of Revenue	1,913	1,831	2,026	2,010	2,057	1,956	2,050	2,109	2,222	1,964	1,755
Total Operating Expenses	308	1,945	374	391	343	354	-169	351	380	333	238
Selling, General & Admin Expense	230	262	248	255	265	272	244	274	285	269	184
Research & Development Expense	31	31	32	33	34	32	32	40	42	37	25
Amortization Expense	40	40	40	38	41	40	41	42	41	30	10
Other Operating Expenses / (Income)	-21	-12	-10	9.00	-11	-11	0.00	-15	-6.00	-3.00	2.00
Other Special Charges / (Income)	28	1,624	64	56	14	21	-486	10	18	-	17
Total Other Income / (Expense), net	-171	-114	-65	-67	-53	-127	-128	-119	-130	-126	13
Interest Expense	202	164	169	174	169	178	185	182	182	168	154
Interest & Investment Income	27	77	86	92	102	95	54	61	57	94	137
Other Income / (Expense), net	4.00	-27	18	15	14	-44	3.00	2.00	-5.00	-52	30
Income Tax Expense	9.00	387	61	29	33	-575	-236	-4.00	25	-840	127
Net Income / (Loss) Discontinued Operations	-5.00	-5.00	-2.00	-1.00	0.00	-6.00	-1.00	1.00	-3.00	-1.00	-1.00
Net Income / (Loss) Attributable to Noncontrolling Interest	4.00	3.00	4.00	-2.00	3.00	3.00	-2.00	1.00	2.00	2.00	2.00
Basic Earnings per Share	($0.19)	($17.52)	$1.06	$1.42	$1.11	$6.42	$8.73	$2.02	$0.84	$7.08	$1.76
Weighted Average Basic Shares Outstanding	109.42M	109.27M	109.34M	109.31M	109.07M	108.85M	108.92M	108.89M	108.63M	108.38M	108.43M
Diluted Earnings per Share	($0.19)	($17.50)	$1.06	$1.41	$1.10	$6.39	$8.69	$2.01	$0.83	$7.00	$1.75
Weighted Average Diluted Shares Outstanding	109.42M	109.27M	109.54M	109.55M	109.51M	109.38M	109.44M	109.31M	109.19M	109.24M	109.07M
Weighted Average Basic & Diluted Shares Outstanding	109.41M	109.33M	109.31M	109.26M	109.22M	217.81M	108.86M	108.85M	108.79M	216.95M	108.43M

This table details how cash moves in and out of Celanese's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-843	297	972	-419	492	24	-114	-62	-329	187
Net Cash From Operating Activities	966	1,899	1,819	1,757	1,343	1,454	1,558	803	893	862
Net Cash From Continuing Operating Activities	971	1,901	1,847	1,742	1,338	1,454	1,568	795	891	864
Net Income / (Loss) Continuing Operations	-1,514	1,964	1,902	1,896	1,992	858	1,213	849	906	285
Consolidated Net Income / (Loss)	-1,514	1,964	1,902	1,896	1,992	858	1,213	849	906	285
Depreciation Expense	823	739	478	378	356	356	349	310	295	363
Amortization Expense	37	66	81	41	-	-	165	46	103	127
Non-Cash Adjustments To Reconcile Net Income	1,594	-426	-70	-126	-1,385	102	-74	-443	-393	51
Changes in Operating Assets and Liabilities, net	31	-442	-544	-447	375	138	-85	33	-20	38
Net Cash From Discontinued Operating Activities	-5.00	-2.00	-28	15	5.00	0.00	-10	8.00	2.00	-2.00
Net Cash From Investing Activities	-470	-134	-11,141	-1,119	592	-493	-507	-549	-439	-558
Net Cash From Continuing Investing Activities	-470	-134	-11,141	-1,119	592	-493	-507	-549	-439	-558
Purchase of Property, Plant & Equipment	-435	-568	-543	-467	-364	-370	-337	-267	-246	-520
Acquisitions	0.00	52	-10,589	-1,142	-100	-91	-144	-269	-178	-6.00
Divestitures	0.00	480	48	-	1,575	0.00	0.00	-	-	-
Sale and/or Maturity of Investments	17	0.00	0.00	516	43	0.00	0.00	-	-	-
Other Investing Activities, net	-52	-98	-57	-53	-39	-17	-39	-14	-27	-36
Net Cash From Financing Activities	-1,313	-1,456	10,290	-1,042	-1,471	-935	-1,165	-351	-759	-66
Net Cash From Continuing Financing Activities	-1,313	-1,456	10,290	-1,042	-1,471	-935	-1,165	-351	-759	-66
Repayment of Debt	-1,477	-4,315	-688	-835	-810	-244	-669	-228	-1,250	-119
Repurchase of Common Equity	0.00	0.00	-17	-1,000	-650	-996	-805	-500	-500	-420
Payment of Dividends	-340	-316	-310	-331	-322	-310	-303	-268	-225	40
Issuance of Debt	503	3,175	11,305	1,196	311	616	612	644	1,210	430
Other Financing Activities, net	1.00	0.00	0.00	-72	0.00	-1.00	0.00	1.00	6.00	3.00
Effect of Exchange Rate Changes	-26	-12	4.00	-	28	-2.00	-	35	-24	-51

This table details how cash moves in and out of Celanese's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-11	149	-372	-298	-322	448	61	129	-341	-8,163	8,888
Net Cash From Operating Activities	37	494	79	292	101	830	403	762	-96	541	467
Net Cash From Continuing Operating Activities	33	493	76	293	109	827	404	767	-97	544	473
Net Income / (Loss) Continuing Operations	-17	-1,911	120	153	124	701	949	221	93	769	193
Consolidated Net Income / (Loss)	-17	-1,911	120	153	124	701	949	221	93	769	193
Depreciation Expense	191	189	209	198	227	195	185	181	178	160	105
Non-Cash Adjustments To Reconcile Net Income	0.00	1,589	4.00	30	-29	34	-456	-28	24	30	-48
Changes in Operating Assets and Liabilities, net	-141	589	-257	-88	-213	-169	-274	393	-392	-496	223
Net Cash From Discontinued Operating Activities	4.00	1.00	3.00	-1.00	-8.00	3.00	-1.00	-5.00	1.00	-3.00	-6.00
Net Cash From Investing Activities	-98	-128	-100	-91	-151	-168	375	-163	-178	-10,713	-143
Net Cash From Continuing Investing Activities	-98	-128	-100	-91	-151	-168	375	-163	-178	-10,713	-143
Purchase of Property, Plant & Equipment	-102	-105	-88	-105	-137	-128	-131	-145	-164	-143	-139
Divestitures	6.00	-	4.00	-	-	-	471	-	-	-	-
Other Investing Activities, net	-2.00	-23	-16	1.00	-14	-40	-17	-18	-23	-27	-4.00
Net Cash From Financing Activities	45	-189	-376	-489	-259	-240	-700	-447	-69	1,944	8,600
Net Cash From Continuing Financing Activities	45	-189	-376	-489	-259	-240	-700	-447	-69	1,944	8,600
Repayment of Debt	-3,227	-15	-542	-484	-436	-163	-3,446	-676	-30	-511	-94
Payment of Dividends	-11	-85	-83	-91	-81	-77	-80	-82	-77	-80	-76
Issuance of Debt	3,283	-89	249	86	257	-	2,826	311	38	2,535	8,770
Other Financing Activities, net	0.00	-	-	-	1.00	-	-	-	0.00	-	-
Effect of Exchange Rate Changes	5.00	-28	25	-10	-13	26	-17	-23	2.00	65	-36

This table presents Celanese's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	22,857	26,597	26,272	11,975	10,909	9,476	9,313	1,579	8,357	8,586
Total Current Assets	5,145	6,218	6,611	3,807	3,763	2,765	2,874	576	2,472	2,787
Cash & Equivalents	962	1,805	1,508	536	955	463	439	576	638	967
Note & Lease Receivable	493	541	675	506	450	331	301	-	223	285
Accounts Receivable	1,121	1,243	1,379	1,161	792	850	1,017	-	801	706
Inventories, net	2,284	2,357	2,808	1,524	978	1,038	1,046	-	720	682
Other Current Assets	285	272	241	80	55	43	40	-	60	49
Plant, Property, & Equipment, net	5,273	5,584	5,584	4,193	3,939	3,713	3,719	0.00	3,577	3,609
Total Noncurrent Assets	12,439	14,795	14,077	3,975	3,207	2,998	2,720	1,003	2,308	2,190
Long-Term Investments	1,217	1,220	1,062	823	820	975	979	-	852	838
Goodwill	5,387	6,977	7,142	1,412	1,166	1,074	1,057	1,003	796	705
Intangible Assets	3,641	3,975	4,105	735	319	312	310	-	194	125
Noncurrent Deferred & Refundable Income Taxes	1,251	1,677	808	248	259	96	84	-	159	222
Other Noncurrent Operating Assets	943	946	960	757	643	541	290	-	307	300
Total Liabilities & Shareholders' Equity	22,857	26,597	26,272	11,975	10,909	9,476	9,313	-177	8,357	8,586
Total Liabilities	17,248	19,045	20,167	7,438	7,014	6,578	5,934	0.00	5,336	5,757
Total Current Liabilities	3,853	4,072	4,068	2,505	1,973	1,754	1,779	0.00	1,077	1,550
Short-Term Debt	1,501	1,383	1,306	791	496	496	561	-	118	513
Accounts Payable	1,228	1,510	1,518	1,160	797	780	819	-	625	587
Current Deferred & Payable Income Tax Liabilities	4.00	25	43	81	0.00	17	56	-	12	120
Other Current Liabilities	1,120	1,154	1,201	473	680	461	343	-	322	330
Total Noncurrent Liabilities	13,395	14,973	16,099	4,933	5,041	4,824	4,155	0.00	4,259	4,207
Long-Term Debt	11,078	12,301	13,373	3,176	3,227	3,409	2,970	-	2,890	2,468
Noncurrent Deferred & Payable Income Tax Liabilities	1,219	1,299	1,564	835	749	422	413	-	261	303
Noncurrent Employee Benefit Liabilities	396	457	411	558	643	589	564	-	893	1,189
Other Noncurrent Operating Liabilities	702	916	751	364	422	404	208	-	215	247
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Equity & Noncontrolling Interests	5,609	7,552	6,105	4,537	3,895	2,898	3,379	3,299	3,021	2,829
Total Preferred & Common Equity	5,175	7,091	5,637	4,189	3,526	2,507	2,984	2,887	2,588	2,378
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Common Equity	5,175	7,091	5,637	4,189	3,526	2,507	2,984	-177	2,588	2,378
Common Stock	409	394	372	333	257	254	233	-	157	136
Retained Earnings	11,100	12,929	11,274	9,677	8,091	6,399	5,847	-	4,320	3,621
Treasury Stock	-5,486	-5,488	-5,491	-5,492	-4,494	-3,846	-2,849	-	-1,531	-1,031
Accumulated Other Comprehensive Income / (Loss)	-848	-744	-518	-329	-328	-300	-247	-177	-358	-348
Noncontrolling Interest	434	461	468	348	369	391	395	-	433	451

This table presents Celanese's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	23,197	22,857	25,892	25,812	26,033	26,597	25,538	25,649	26,090	26,272	21,337
Total Current Assets	5,418	5,145	5,706	5,904	5,945	6,218	5,887	6,252	6,448	6,611	13,192
Cash & Equivalents	951	962	813	1,185	1,483	1,805	1,357	1,296	1,167	1,508	9,671
Note & Lease Receivable	640	493	688	662	536	541	570	625	707	675	492
Accounts Receivable	1,240	1,121	1,367	1,264	1,289	1,243	1,339	1,338	1,606	1,379	1,120
Inventories, net	2,309	2,284	2,562	2,464	2,354	2,357	2,337	2,514	2,749	2,808	1,723
Other Current Assets	278	285	276	329	283	272	284	268	219	241	186
Plant, Property, & Equipment, net	5,259	5,273	5,431	5,382	5,471	5,584	5,467	5,541	5,588	5,584	4,089
Total Noncurrent Assets	12,520	12,439	14,755	14,526	14,617	14,795	14,184	13,856	14,054	14,077	4,056
Long-Term Investments	1,220	1,217	1,253	1,215	1,238	1,220	1,245	1,028	1,049	1,062	954
Goodwill	5,413	5,387	6,997	6,899	6,926	6,977	6,991	7,063	7,139	7,142	1,294
Intangible Assets	3,670	3,641	3,858	3,844	3,902	3,975	3,944	4,007	4,086	4,105	645
Noncurrent Deferred & Refundable Income Taxes	1,295	1,251	1,672	1,608	1,618	1,677	1,074	832	813	808	222
Other Noncurrent Operating Assets	922	943	975	960	933	946	930	926	967	960	941
Total Liabilities & Shareholders' Equity	23,197	22,857	25,892	25,812	26,033	26,597	25,538	25,649	26,090	26,272	21,337
Total Liabilities	17,582	17,248	18,174	18,203	18,502	19,045	18,589	19,561	19,960	20,167	16,043
Total Current Liabilities	2,797	3,853	4,159	4,626	4,925	4,072	3,616	3,922	3,851	4,068	2,788
Short-Term Debt	406	1,501	1,607	1,977	2,439	1,383	1,408	1,507	1,386	1,306	977
Accounts Payable	1,314	1,228	1,446	1,538	1,447	1,510	1,263	1,243	1,445	1,518	1,128
Current Deferred & Payable Income Tax Liabilities	80	4.00	23	5.00	28	25	18	7.00	6.00	43	128
Other Current Liabilities	997	1,120	1,083	1,106	1,011	1,154	927	1,146	1,014	1,201	555
Total Noncurrent Liabilities	14,785	13,395	14,015	13,577	13,577	14,973	14,973	15,639	16,109	16,099	13,255
Long-Term Debt	12,378	11,078	11,324	11,058	11,018	12,301	12,291	12,889	13,396	13,373	11,360
Noncurrent Deferred & Payable Income Tax Liabilities	1,215	1,219	1,314	1,331	1,314	1,299	1,499	1,505	1,518	1,564	954
Noncurrent Employee Benefit Liabilities	396	396	440	435	444	457	396	406	411	411	489
Other Noncurrent Operating Liabilities	796	702	937	753	801	916	787	839	784	751	452
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,615	5,609	7,718	7,609	7,531	7,552	6,949	6,088	6,130	6,105	5,294
Total Preferred & Common Equity	5,186	5,175	7,274	7,166	7,071	7,091	6,491	5,624	5,661	5,637	4,950
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,186	5,175	7,274	7,166	7,071	7,091	6,491	5,624	5,661	5,637	4,950
Common Stock	413	409	397	394	383	394	386	383	365	372	356
Retained Earnings	11,076	11,100	13,091	13,051	12,973	12,929	12,308	11,433	11,289	11,274	10,584
Treasury Stock	-5,486	-5,486	-5,487	-5,487	-5,488	-5,488	-5,490	-5,490	-5,491	-5,491	-5,492
Accumulated Other Comprehensive Income / (Loss)	-817	-848	-727	-792	-797	-744	-713	-702	-502	-518	-498
Noncontrolling Interest	429	434	444	443	460	461	458	464	469	468	344

This table displays calculated financial ratios and metrics derived from Celanese's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.03%	13.10%	13.31%	50.96%	-10.20%	-11.99%	16.53%	13.94%	-5.02%	-16.58%
EBITDA Growth	-92.52%	24.71%	-20.40%	136.66%	-10.33%	-35.23%	42.38%	-2.25%	59.53%	-42.37%
EBIT Growth	-141.21%	17.02%	-31.41%	198.40%	-14.89%	-37.03%	41.59%	1.46%	180.19%	-57.82%
NOPAT Growth	-117.34%	51.90%	11.56%	180.87%	-18.95%	-32.22%	56.40%	-16.44%	329.45%	-62.04%
Net Income Growth	-177.09%	3.26%	0.32%	-4.82%	132.17%	-29.27%	42.87%	-6.29%	217.89%	-54.03%
EPS Growth	-177.73%	3.34%	2.85%	0.66%	144.88%	-23.23%	46.31%	-1.46%	209.00%	-50.00%
Operating Cash Flow Growth	-49.13%	4.40%	3.53%	30.83%	-7.63%	-6.68%	94.02%	-10.08%	3.60%	-10.40%
Free Cash Flow Firm Growth	-39.14%	130.56%	-5,176.77%	-128.82%	-29.95%	125.59%	-180.64%	1,349.35%	-12.24%	14.07%
Invested Capital Growth	-12.09%	-0.02%	154.92%	34.56%	-0.28%	-2.49%	444.47%	-77.76%	13.43%	-3.36%
Revenue Q/Q Growth	-1.90%	2.06%	0.76%	8.71%	2.89%	-3.92%	1.36%	4.81%	-0.43%	-3.81%
EBITDA Q/Q Growth	-89.83%	14.61%	-15.61%	17.37%	23.46%	-10.06%	4.67%	14.34%	61.93%	-10.12%
EBIT Q/Q Growth	-169.79%	14.73%	-26.42%	18.19%	40.57%	-13.89%	-7.04%	13.14%	90.79%	-44.21%
NOPAT Q/Q Growth	-129.85%	-8.65%	23.52%	16.77%	34.37%	-12.86%	-1.05%	4.84%	136.74%	-52.33%
Net Income Q/Q Growth	-237.89%	-3.35%	14.65%	-32.86%	241.68%	-6.13%	-7.83%	5.34%	104.05%	-43.11%
EPS Q/Q Growth	-239.86%	-3.29%	15.22%	-30.99%	242.54%	-4.87%	-7.38%	5.91%	98.71%	-41.00%
Operating Cash Flow Q/Q Growth	-25.81%	17.95%	-2.31%	21.42%	-3.73%	-2.48%	24.34%	15.04%	-17.01%	-3.36%
Free Cash Flow Firm Q/Q Growth	56.21%	135.38%	-2,515.46%	-120.01%	27.89%	-22.53%	-739.95%	1,094.46%	-57.62%	76.14%
Invested Capital Q/Q Growth	-13.85%	0.91%	159.98%	21.35%	-0.54%	-0.89%	-3.40%	-80.31%	12.28%	-8.64%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.92%	23.79%	24.60%	31.42%	22.86%	25.50%	27.56%	24.61%	26.07%	23.23%
EBITDA Margin	1.78%	22.38%	20.29%	28.89%	18.43%	18.45%	25.07%	20.52%	23.92%	14.24%
Operating Margin	-6.78%	15.42%	14.25%	22.79%	11.74%	13.24%	18.64%	13.97%	17.33%	5.75%
EBIT Margin	-6.59%	15.02%	14.51%	23.98%	12.13%	12.80%	17.89%	14.72%	16.53%	5.60%
Profit (Net Income) Margin	-14.73%	17.95%	19.66%	22.21%	35.23%	13.63%	16.95%	13.83%	16.81%	5.02%
Tax Burden Percent	152.01%	166.02%	133.85%	84.34%	88.49%	86.84%	80.33%	78.98%	87.96%	58.40%
Interest Burden Percent	147.12%	72.00%	101.21%	109.82%	328.13%	122.58%	117.97%	118.92%	115.60%	153.46%
Effective Tax Rate	0.00%	-66.78%	-34.41%	14.68%	10.97%	12.55%	19.34%	19.81%	11.84%	41.19%
Return on Invested Capital (ROIC)	-2.85%	15.45%	14.61%	26.66%	11.12%	13.52%	33.29%	24.96%	19.41%	4.74%
ROIC Less NNEP Spread (ROIC-NNEP)	-12.60%	7.99%	15.28%	38.38%	84.04%	19.23%	-94.71%	-14.89%	25.68%	13.29%
Return on Net Nonoperating Assets (RNNOA)	-20.16%	13.31%	21.14%	18.31%	47.53%	13.81%	3.04%	1.90%	11.56%	4.91%
Return on Equity (ROE)	-23.01%	28.76%	35.75%	44.97%	58.65%	27.34%	36.33%	26.87%	30.97%	9.65%
Cash Return on Invested Capital (CROIC)	10.02%	15.47%	-72.69%	-2.80%	11.40%	16.05%	-104.64%	152.18%	6.82%	8.15%
Operating Return on Assets (OROA)	-2.74%	6.22%	7.34%	17.89%	6.73%	8.58%	23.50%	18.20%	10.52%	3.66%
Return on Assets (ROA)	-6.12%	7.43%	9.95%	16.57%	19.54%	9.13%	22.27%	17.09%	10.69%	3.28%
Return on Common Equity (ROCE)	-21.44%	26.81%	33.00%	41.15%	52.09%	23.91%	15.27%	10.25%	26.29%	8.49%
Return on Equity Simple (ROE_SIMPLE)	-29.26%	27.70%	33.74%	45.26%	56.49%	34.22%	40.65%	29.41%	35.01%	11.98%
Net Operating Profit after Tax (NOPAT)	-488	2,814	1,852	1,660	591	729	1,076	688	823	192
NOPAT Margin	-4.75%	25.72%	19.15%	19.45%	10.45%	11.58%	15.04%	11.21%	15.28%	3.38%
Net Nonoperating Expense Percent (NNEP)	9.75%	7.46%	-0.68%	-11.72%	-72.92%	-5.71%	128.01%	39.85%	-6.27%	-8.55%
Return On Investment Capital (ROIC_SIMPLE)	-2.68%	13.25%	8.91%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	77.08%	76.21%	75.40%	68.58%	77.14%	74.50%	72.44%	75.39%	73.93%	76.77%
SG&A Expenses to Revenue	10.02%	9.83%	8.52%	7.41%	8.52%	7.67%	7.63%	8.08%	7.01%	8.92%
R&D to Revenue	1.26%	1.33%	1.16%	1.01%	1.31%	1.06%	1.01%	1.19%	1.45%	2.10%
Operating Expenses to Revenue	29.70%	8.37%	10.41%	8.62%	11.12%	12.26%	8.92%	10.64%	8.74%	17.48%
Earnings before Interest and Taxes (EBIT)	-677	1,643	1,404	2,047	686	806	1,280	904	891	318
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	183	2,448	1,963	2,466	1,042	1,162	1,794	1,260	1,289	808
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.46	2.34	1.88	4.11	3.98	5.35	3.55	0.00	3.70	3.45
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	8.43	6.87	11.95	6.56	0.00	5.98	5.30
Price to Revenue (P/Rev)	0.74	1.52	1.10	2.02	2.48	2.13	1.48	2.04	1.77	1.45
Price to Earnings (P/E)	0.00	8.46	5.60	9.11	7.07	15.73	8.78	14.88	10.63	26.99
Dividend Yield	4.05%	1.84%	2.80%	1.72%	2.07%	2.16%	2.62%	1.88%	2.07%	2.06%
Earnings Yield	0.00%	11.82%	17.85%	10.98%	14.15%	6.36%	11.38%	6.72%	9.41%	3.71%
Enterprise Value to Invested Capital (EV/IC)	1.15	1.52	1.27	2.82	2.98	3.05	2.40	11.94	2.55	2.47
Enterprise Value to Revenue (EV/Rev)	1.79	2.53	2.40	2.36	2.80	2.58	1.83	1.95	2.13	1.73
Enterprise Value to EBITDA (EV/EBITDA)	100.54	11.32	11.81	8.18	15.18	13.96	7.29	9.50	8.91	12.13
Enterprise Value to EBIT (EV/EBIT)	0.00	16.86	16.51	9.85	23.05	20.12	10.22	13.24	12.89	30.82
Enterprise Value to NOPAT (EV/NOPAT)	0.00	9.85	12.52	12.15	26.75	22.24	12.16	17.40	13.95	51.12
Enterprise Value to Operating Cash Flow (EV/OCF)	19.05	14.59	12.75	11.48	11.77	11.15	8.40	14.91	12.86	11.37
Enterprise Value to Free Cash Flow (EV/FCFF)	10.73	9.84	0.00	0.00	26.09	18.74	0.00	2.85	39.69	29.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.24	1.81	2.40	0.87	0.96	1.35	1.05	0.00	1.00	1.05
Long-Term Debt to Equity	1.98	1.63	2.19	0.70	0.83	1.18	0.88	0.00	0.96	0.87
Financial Leverage	1.60	1.67	1.38	0.48	0.57	0.72	-0.03	-0.13	0.45	0.37
Leverage Ratio	3.76	3.87	3.59	2.71	3.00	2.99	1.63	1.57	2.90	2.94
Compound Leverage Factor	5.53	2.79	3.64	2.98	9.85	3.67	1.92	1.87	3.35	4.52
Debt to Total Capital	69.16%	64.44%	70.63%	46.65%	48.87%	57.40%	51.10%	0.00%	49.89%	51.31%
Short-Term Debt to Total Capital	8.25%	6.51%	6.28%	9.30%	6.51%	7.29%	8.12%	0.00%	1.96%	8.83%
Long-Term Debt to Total Capital	60.91%	57.93%	64.34%	37.35%	42.36%	50.11%	42.98%	0.00%	47.94%	42.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.39%	2.17%	2.25%	4.09%	4.84%	5.75%	5.72%	0.00%	7.18%	7.76%
Common Equity to Total Capital	28.45%	33.39%	27.12%	49.26%	46.29%	36.85%	43.18%	-5.37%	42.93%	40.93%
Debt to EBITDA	68.74	5.59	7.48	1.61	3.57	3.36	1.97	0.00	2.33	3.69
Net Debt to EBITDA	56.83	4.35	6.17	1.06	1.36	2.09	1.16	0.00	1.15	1.42
Long-Term Debt to EBITDA	60.54	5.02	6.81	1.29	3.10	2.93	1.66	0.00	2.24	3.05
Debt to NOPAT	-25.78	4.86	7.93	2.39	6.30	5.35	3.28	0.00	3.65	15.55
Net Debt to NOPAT	-21.32	3.79	6.54	1.57	2.39	3.33	1.93	0.00	1.81	5.98
Long-Term Debt to NOPAT	-22.71	4.37	7.22	1.91	5.46	4.67	2.76	0.00	3.51	12.87
Altman Z-Score	1.36	1.92	1.58	3.93	3.16	3.24	3.31	0.00	3.00	2.40
Noncontrolling Interest Sharing Ratio	6.80%	6.80%	7.67%	8.50%	11.19%	12.52%	57.97%	61.85%	15.11%	12.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.34	1.53	1.63	1.52	1.91	1.58	1.62	0.00	2.30	1.80
Quick Ratio	0.67	0.88	0.88	0.88	1.38	0.96	1.01	0.00	1.57	1.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,714	2,817	-9,217	-175	606	865	-3,382	4,194	289	330
Operating Cash Flow to CapEx	222.07%	334.33%	334.99%	399.32%	391.55%	394.04%	480.86%	301.88%	381.62%	167.05%
Free Cash Flow to Firm to Interest Expense	2.54	3.87	-22.76	-1.75	5.56	7.27	-26.84	34.38	2.30	2.77
Operating Cash Flow to Interest Expense	1.43	2.61	4.49	17.57	12.32	12.22	12.37	6.58	7.09	7.24
Operating Cash Flow Less CapEx to Interest Expense	0.79	1.83	3.15	13.17	9.17	9.12	9.79	4.40	5.23	2.91
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.42	0.41	0.51	0.75	0.55	0.67	1.31	1.24	0.64	0.65
Accounts Receivable Turnover	8.70	8.34	7.62	8.74	6.89	6.75	0.00	0.00	7.15	7.53
Inventory Turnover	3.41	3.23	3.37	4.68	4.33	4.50	0.00	0.00	5.68	5.95
Fixed Asset Turnover	1.89	1.96	1.98	2.10	1.48	1.69	0.00	0.00	1.50	1.55
Accounts Payable Turnover	5.79	5.51	5.45	5.98	5.53	5.87	0.00	0.00	6.57	6.48
Days Sales Outstanding (DSO)	41.97	43.74	47.92	41.75	52.99	54.11	0.00	0.00	51.04	48.47
Days Inventory Outstanding (DIO)	106.89	113.06	108.40	77.99	84.35	81.08	0.00	0.00	64.22	61.34
Days Payable Outstanding (DPO)	63.06	66.28	67.01	61.00	65.98	62.21	0.00	0.00	55.52	56.31
Cash Conversion Cycle (CCC)	85.80	90.52	89.31	58.74	71.36	72.98	0.00	0.00	59.74	53.50
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	16,009	18,211	18,214	7,145	5,310	5,325	5,461	1,003	4,509	3,975
Invested Capital Turnover	0.60	0.60	0.76	1.37	1.06	1.17	2.21	2.23	1.27	1.40
Increase / (Decrease) in Invested Capital	-2,202	-3.00	11,069	1,835	-15	-136	4,458	-3,506	534	-138
Enterprise Value (EV)	18,399	27,702	23,186	20,170	15,813	16,219	13,080	11,971	11,484	9,802
Market Capitalization	7,565	16,582	10,609	17,214	14,029	13,401	10,603	12,547	9,563	8,205
Book Value per Share	$47.34	$65.14	$51.99	$38.48	$30.16	$20.74	$22.31	($1.31)	$18.07	$16.21
Tangible Book Value per Share	($35.25)	($35.47)	($51.74)	$18.76	$17.46	$9.27	$12.09	($8.70)	$11.16	$10.55
Total Capital	18,188	21,236	20,784	8,504	7,618	6,803	6,910	3,299	6,029	5,810
Total Debt	12,579	13,684	14,679	3,967	3,723	3,905	3,531	0.00	3,008	2,981
Total Long-Term Debt	11,078	12,301	13,373	3,176	3,227	3,409	2,970	0.00	2,890	2,468
Net Debt	10,400	10,659	12,109	2,608	1,415	2,427	2,082	-576	1,488	1,146
Capital Expenditures (CapEx)	435	568	543	440	343	369	324	266	234	516
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,831	1,724	2,341	1,557	798	1,004	1,186	0.00	845	753
Debt-free Net Working Capital (DFNWC)	2,793	3,529	3,849	2,093	2,286	1,507	1,656	576	1,513	1,750
Net Working Capital (NWC)	1,292	2,146	2,543	1,302	1,790	1,011	1,095	576	1,395	1,237
Net Nonoperating Expense (NNE)	1,026	850	-50	-236	-1,401	-129	-137	-161	-83	-93
Net Nonoperating Obligations (NNO)	10,400	10,659	12,109	2,608	1,415	2,427	2,082	-2,296	1,488	1,146
Total Depreciation and Amortization (D&A)	860	805	559	419	356	356	514	356	398	490
Debt-free, Cash-free Net Working Capital to Revenue	17.81%	15.76%	24.20%	18.24%	14.11%	15.94%	16.58%	0.00%	15.68%	13.27%
Debt-free Net Working Capital to Revenue	27.17%	32.26%	39.79%	24.52%	40.42%	23.93%	23.14%	9.38%	28.08%	30.84%
Net Working Capital to Revenue	12.57%	19.62%	26.29%	15.25%	31.65%	16.06%	15.30%	9.38%	25.89%	21.80%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($13.93)	$18.01	$17.48	$16.99	$16.85	$6.88	$8.99	$6.11	$6.21	$2.02
Adjusted Weighted Average Basic Shares Outstanding	109.27M	108.85M	108.38M	111.22M	117.82M	123.93M	134.31M	137.90M	144.94M	150.84M
Adjusted Diluted Earnings per Share	($13.93)	$17.92	$17.34	$16.86	$16.75	$6.84	$8.91	$6.09	$6.18	$2.00
Adjusted Weighted Average Diluted Shares Outstanding	109.27M	109.38M	109.24M	112.08M	118.48M	124.65M	135.42M	138.32M	145.67M	152.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	109.33M	217.81M	216.95M	216.06M	228.35M	119.56M	128.10M	135.82M	140.93M	147.08M
Normalized Net Operating Profit after Tax (NOPAT)	743	875	970	1,655	632	909	1,073	739	828	403
Normalized NOPAT Margin	7.22%	8.00%	10.03%	19.39%	11.18%	14.43%	14.99%	12.04%	15.36%	7.11%
Pre Tax Income Margin	-9.69%	10.81%	14.69%	26.33%	39.81%	15.69%	21.10%	17.51%	19.11%	8.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.00	2.26	3.47	20.47	6.29	6.77	10.16	7.41	7.07	2.67
NOPAT to Interest Expense	-0.72	3.87	4.57	16.60	5.42	6.13	8.54	5.64	6.53	1.61
EBIT Less CapEx to Interest Expense	-1.65	1.48	2.13	16.07	3.15	3.67	7.59	5.23	5.21	-1.66
NOPAT Less CapEx to Interest Expense	-1.37	3.09	3.23	12.20	2.28	3.03	5.97	3.46	4.68	-2.73
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-22.46%	16.09%	16.30%	17.46%	16.16%	36.13%	24.98%	31.57%	24.83%	-14.04%
Augmented Payout Ratio	-22.46%	16.09%	17.19%	70.20%	48.80%	152.21%	91.34%	90.46%	80.02%	133.33%

This table displays calculated financial ratios and metrics derived from Celanese's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.50%	-7.75%	-2.75%	-5.15%	-8.48%	9.41%	18.34%	12.43%	12.41%	3.21%	1.54%
EBITDA Growth	-19.51%	-403.17%	-53.88%	-10.62%	6.37%	150.00%	132.51%	-15.36%	-36.05%	-73.03%	-33.38%
EBIT Growth	-23.21%	-766.05%	-68.52%	-21.37%	-8.94%	5,275.00%	150.00%	-33.27%	-55.83%	-99.21%	-40.81%
NOPAT Growth	-29.10%	-170.90%	-85.24%	-38.34%	-16.71%	3,438.83%	501.85%	-11.46%	-54.16%	-92.03%	-58.46%
Net Income Growth	-113.71%	-372.61%	-87.36%	-30.77%	33.33%	-8.84%	391.71%	-49.31%	-81.55%	46.20%	-61.93%
EPS Growth	-117.27%	-373.87%	-87.80%	-29.85%	32.53%	-8.71%	396.57%	-49.50%	-82.00%	48.62%	-61.62%
Operating Cash Flow Growth	-63.37%	-40.48%	-80.40%	-61.68%	205.21%	53.42%	-13.70%	53.94%	-130.38%	-7.36%	-25.87%
Free Cash Flow Firm Growth	262.54%	-12.35%	96.25%	99.36%	105.40%	112.60%	-964.51%	-896.07%	-670.91%	-721.24%	-823.57%
Invested Capital Growth	-11.16%	-12.09%	2.98%	1.54%	-2.29%	-0.02%	157.58%	145.10%	149.81%	154.92%	18.99%
Revenue Q/Q Growth	0.80%	-10.50%	-0.11%	1.53%	1.63%	-5.66%	-2.58%	-2.03%	21.51%	2.04%	-7.44%
EBITDA Q/Q Growth	129.20%	-361.68%	2.59%	2.66%	10.00%	-60.19%	98.84%	22.17%	158.54%	-62.98%	-27.61%
EBIT Q/Q Growth	112.01%	-638.35%	0.38%	18.30%	4.19%	-74.56%	150.74%	36.99%	6,050.00%	-98.82%	-33.07%
NOPAT Q/Q Growth	111.96%	-694.86%	-21.41%	26.84%	-88.04%	23.82%	228.34%	71.34%	408.01%	-78.94%	-51.70%
Net Income Q/Q Growth	99.11%	-1,692.50%	-21.57%	23.39%	-82.31%	-26.13%	329.41%	137.63%	-87.91%	298.45%	-55.73%
EPS Q/Q Growth	98.91%	-1,750.94%	-24.82%	28.18%	-82.79%	-26.47%	332.34%	142.17%	-88.14%	300.00%	-56.03%
Operating Cash Flow Q/Q Growth	-92.51%	525.32%	-72.95%	189.11%	-87.83%	105.96%	-47.11%	893.75%	-117.74%	15.85%	-5.66%
Free Cash Flow Firm Q/Q Growth	76.99%	427.85%	-466.41%	-111.03%	-57.21%	114.01%	3.65%	6.51%	0.15%	-1,083.64%	9.85%
Invested Capital Q/Q Growth	1.37%	-13.85%	1.86%	-0.13%	0.31%	0.91%	0.43%	-3.89%	2.65%	159.98%	-4.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.92%	22.74%	23.49%	24.18%	21.22%	23.86%	24.72%	24.54%	22.12%	16.35%	23.73%
EBITDA Margin	15.19%	-52.45%	17.94%	17.47%	17.27%	15.96%	37.83%	18.53%	14.86%	6.98%	19.25%
Operating Margin	7.03%	-59.28%	9.37%	9.43%	8.04%	10.08%	30.92%	11.99%	8.80%	2.39%	13.39%
EBIT Margin	7.20%	-60.42%	10.05%	10.00%	8.58%	8.37%	31.03%	12.06%	8.62%	0.17%	14.69%
Profit (Net Income) Margin	-0.71%	-80.63%	4.53%	5.77%	4.75%	27.29%	34.85%	7.91%	3.26%	32.75%	8.39%
Tax Burden Percent	566.67%	125.81%	65.57%	83.61%	78.98%	531.06%	132.91%	102.31%	76.86%	-1,098.57%	60.12%
Interest Burden Percent	-1.74%	106.08%	68.80%	69.06%	70.09%	61.40%	84.50%	64.10%	49.19%	-1,750.00%	94.97%
Effective Tax Rate	0.00%	0.00%	33.33%	15.85%	21.02%	-435.61%	-33.05%	-1.85%	20.66%	0.00%	39.56%
Return on Invested Capital (ROIC)	2.87%	-24.93%	3.57%	4.63%	3.68%	32.44%	35.21%	9.94%	5.33%	1.27%	12.05%
ROIC Less NNEP Spread (ROIC-NNEP)	1.61%	-33.74%	3.16%	4.12%	3.32%	26.41%	32.53%	8.22%	3.92%	11.19%	12.46%
Return on Net Nonoperating Assets (RNNOA)	2.61%	-53.99%	4.73%	6.77%	5.66%	44.03%	34.04%	10.16%	5.34%	15.48%	4.34%
Return on Equity (ROE)	5.48%	-78.92%	8.30%	11.39%	9.34%	76.46%	69.24%	20.10%	10.67%	16.75%	16.38%
Cash Return on Invested Capital (CROIC)	8.82%	10.02%	5.99%	12.54%	16.94%	15.47%	-63.55%	-67.74%	-72.05%	-72.69%	5.92%
Operating Return on Assets (OROA)	2.94%	-25.12%	4.09%	4.10%	3.52%	3.46%	14.19%	6.47%	4.47%	0.09%	8.57%
Return on Assets (ROA)	-0.29%	-33.52%	1.85%	2.37%	1.95%	11.29%	15.94%	4.24%	1.69%	16.57%	4.89%
Return on Common Equity (ROCE)	5.11%	-73.56%	7.79%	10.64%	8.70%	71.26%	64.71%	18.66%	9.88%	15.47%	15.19%
Return on Equity Simple (ROE_SIMPLE)	-31.91%	0.00%	15.09%	26.89%	28.21%	0.00%	31.30%	22.69%	26.34%	0.00%	33.52%
Net Operating Profit after Tax (NOPAT)	118	-984	165	210	166	1,387	1,120	341	199	39	186
NOPAT Margin	4.92%	-41.50%	6.24%	7.94%	6.35%	54.00%	41.14%	12.21%	6.98%	1.67%	8.09%
Net Nonoperating Expense Percent (NNEP)	1.26%	8.81%	0.41%	0.51%	0.36%	6.03%	2.67%	1.72%	1.41%	-9.92%	-0.41%
Return On Investment Capital (ROIC_SIMPLE)	0.64%	-5.41%	-	-	-	6.53%	-	-	-	0.19%	-
Cost of Revenue to Revenue	80.08%	77.26%	76.51%	75.82%	78.78%	76.14%	75.28%	75.46%	77.88%	83.65%	76.27%
SG&A Expenses to Revenue	9.63%	11.05%	9.37%	9.62%	10.15%	10.59%	8.96%	9.80%	9.99%	11.46%	8.00%
R&D to Revenue	1.30%	1.31%	1.21%	1.24%	1.30%	1.25%	1.18%	1.43%	1.47%	1.58%	1.09%
Operating Expenses to Revenue	12.89%	82.07%	14.12%	14.75%	13.14%	13.78%	-6.21%	12.56%	13.32%	14.18%	10.34%
Earnings before Interest and Taxes (EBIT)	172	-1,432	266	265	224	215	845	337	246	4.00	338
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	363	-1,243	475	463	451	410	1,030	518	424	164	443
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.20	1.46	2.03	2.05	2.62	2.34	2.05	2.18	2.02	1.88	1.89
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.11
Price to Revenue (P/Rev)	0.62	0.74	1.41	1.39	1.73	1.52	1.24	1.19	1.14	1.10	0.97
Price to Earnings (P/E)	0.00	0.00	13.55	7.61	9.31	8.46	6.56	9.67	7.71	5.60	5.66
Dividend Yield	3.75%	4.05%	2.07%	2.09%	1.65%	1.84%	2.29%	2.46%	2.62%	2.80%	3.15%
Earnings Yield	0.00%	0.00%	7.38%	13.13%	10.74%	11.82%	15.24%	10.34%	12.97%	17.85%	17.66%
Enterprise Value to Invested Capital (EV/IC)	1.06	1.15	1.40	1.41	1.63	1.52	1.38	1.38	1.31	1.27	1.63
Enterprise Value to Revenue (EV/Rev)	1.71	1.79	2.49	2.44	2.78	2.53	2.32	2.41	2.45	2.40	1.19
Enterprise Value to EBITDA (EV/EBITDA)	297.32	100.54	14.50	10.93	12.34	11.32	11.64	16.02	14.89	11.81	4.90
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	26.89	16.61	18.34	16.86	17.37	26.82	22.39	16.51	5.98
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	15.96	10.11	11.00	9.85	8.08	12.00	13.74	12.52	7.61
Enterprise Value to Operating Cash Flow (EV/OCF)	19.12	19.05	20.03	15.83	14.18	14.59	15.45	14.82	17.39	12.75	6.13
Enterprise Value to Free Cash Flow (EV/FCFF)	11.33	10.73	23.77	11.33	9.49	9.84	0.00	0.00	0.00	0.00	29.89
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.28	2.24	1.68	1.71	1.79	1.81	1.97	2.36	2.41	2.40	2.33
Long-Term Debt to Equity	2.20	1.98	1.47	1.45	1.46	1.63	1.77	2.12	2.19	2.19	2.15
Financial Leverage	1.62	1.60	1.50	1.64	1.71	1.67	1.05	1.24	1.36	1.38	0.35
Leverage Ratio	3.74	3.76	3.51	3.76	3.82	3.87	3.83	3.39	3.48	3.59	3.44
Compound Leverage Factor	-0.07	3.99	2.41	2.59	2.67	2.38	3.24	2.17	1.71	-62.89	3.27
Debt to Total Capital	69.48%	69.16%	62.62%	63.14%	64.12%	64.44%	66.35%	70.28%	70.69%	70.63%	69.97%
Short-Term Debt to Total Capital	2.21%	8.25%	7.78%	9.58%	11.62%	6.51%	6.82%	7.36%	6.63%	6.28%	5.54%
Long-Term Debt to Total Capital	67.28%	60.91%	54.84%	53.57%	52.50%	57.93%	59.53%	62.92%	64.06%	64.34%	64.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.33%	2.39%	2.15%	2.15%	2.19%	2.17%	2.22%	2.27%	2.24%	2.25%	1.95%
Common Equity to Total Capital	28.19%	28.45%	35.23%	34.71%	33.69%	33.39%	31.44%	27.46%	27.07%	27.12%	28.08%
Debt to EBITDA	220.41	68.74	7.19	5.54	5.59	5.59	6.41	9.29	9.00	7.48	5.30
Net Debt to EBITDA	182.98	56.83	6.04	4.52	4.46	4.35	5.20	7.79	7.65	6.17	0.74
Long-Term Debt to EBITDA	213.41	60.54	6.29	4.70	4.57	5.02	5.75	8.32	8.15	6.81	4.88
Debt to NOPAT	-24.71	-25.78	7.91	5.12	4.98	4.86	4.45	6.96	8.30	7.93	8.23
Net Debt to NOPAT	-20.52	-21.32	6.65	4.18	3.97	3.79	3.60	5.84	7.06	6.54	1.14
Long-Term Debt to NOPAT	-23.93	-22.71	6.93	4.34	4.08	4.37	3.99	6.23	7.52	7.22	7.58
Altman Z-Score	1.47	1.25	1.71	1.69	1.78	1.74	1.74	1.55	1.48	1.40	2.13
Noncontrolling Interest Sharing Ratio	6.76%	6.80%	6.15%	6.62%	6.80%	6.80%	6.55%	7.15%	7.35%	7.67%	7.28%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.94	1.34	1.37	1.28	1.21	1.53	1.63	1.59	1.67	1.63	4.73
Quick Ratio	1.01	0.67	0.69	0.67	0.67	0.88	0.90	0.83	0.90	0.88	4.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,157	1,219	-372	-66	595	1,390	-9,920	-10,296	-11,013	-11,030	-932
Operating Cash Flow to CapEx	36.27%	470.48%	89.77%	278.10%	73.72%	648.44%	307.63%	525.52%	-61.94%	378.32%	335.97%
Free Cash Flow to Firm to Interest Expense	10.68	7.43	-2.20	-0.38	3.52	7.81	-53.62	-56.57	-60.51	-65.65	-6.05
Operating Cash Flow to Interest Expense	0.18	3.01	0.47	1.68	0.60	4.66	2.18	4.19	-0.53	3.22	3.03
Operating Cash Flow Less CapEx to Interest Expense	-0.32	2.37	-0.05	1.07	-0.21	3.94	1.47	3.39	-1.38	2.37	2.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.42	0.41	0.41	0.41	0.41	0.46	0.54	0.52	0.51	0.58
Accounts Receivable Turnover	7.95	8.70	7.75	8.11	7.39	8.34	8.72	7.76	6.67	7.62	8.38
Inventory Turnover	3.34	3.41	3.29	3.24	3.20	3.23	4.11	3.81	3.59	3.37	4.78
Fixed Asset Turnover	1.87	1.89	1.92	1.93	1.93	1.96	2.24	2.12	2.04	1.98	2.40
Accounts Payable Turnover	5.64	5.79	5.94	5.81	5.65	5.51	6.98	6.46	5.91	5.45	6.34
Days Sales Outstanding (DSO)	45.89	41.97	47.13	44.99	49.39	43.74	41.87	47.06	54.74	47.92	43.57
Days Inventory Outstanding (DIO)	109.38	106.89	111.08	112.53	113.96	113.06	88.79	95.83	101.58	108.40	76.42
Days Payable Outstanding (DPO)	64.77	63.06	61.42	62.87	64.59	66.28	52.29	56.52	61.78	67.01	57.54
Cash Conversion Cycle (CCC)	90.50	85.80	96.78	94.66	98.76	90.52	78.37	86.37	94.54	89.31	62.45
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	16,228	16,009	18,583	18,244	18,267	18,211	18,046	17,968	18,696	18,214	7,006
Invested Capital Turnover	0.58	0.60	0.57	0.58	0.58	0.60	0.86	0.81	0.76	0.76	1.49
Increase / (Decrease) in Invested Capital	-2,039	-2,202	537	276	-429	-3.00	11,040	10,637	11,212	11,069	1,118
Enterprise Value (EV)	17,245	18,399	26,083	25,737	29,725	27,702	24,871	24,813	24,468	23,186	11,407
Market Capitalization	6,203	7,565	14,774	14,659	18,529	16,582	13,316	12,277	11,433	10,609	9,351
Book Value per Share	$47.43	$47.34	$66.57	$65.61	$64.83	$65.14	$59.63	$51.70	$52.19	$51.99	$45.69
Tangible Book Value per Share	($35.64)	($35.25)	($32.77)	($32.75)	($34.45)	($35.47)	($40.83)	($50.06)	($51.29)	($51.74)	$27.79
Total Capital	18,399	18,188	20,649	20,644	20,988	21,236	20,648	20,484	20,912	20,784	17,631
Total Debt	12,784	12,579	12,931	13,035	13,457	13,684	13,699	14,396	14,782	14,679	12,337
Total Long-Term Debt	12,378	11,078	11,324	11,058	11,018	12,301	12,291	12,889	13,396	13,373	11,360
Net Debt	10,613	10,400	10,865	10,635	10,736	10,659	11,097	12,072	12,566	12,109	1,712
Capital Expenditures (CapEx)	102	105	88	105	137	128	131	145	155	143	139
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,076	1,831	2,341	2,070	1,976	1,724	2,322	2,541	2,816	2,341	1,710
Debt-free Net Working Capital (DFNWC)	3,027	2,793	3,154	3,255	3,459	3,529	3,679	3,837	3,983	3,849	11,381
Net Working Capital (NWC)	2,621	1,292	1,547	1,278	1,020	2,146	2,271	2,330	2,597	2,543	10,404
Net Nonoperating Expense (NNE)	135	928	45	57	42	686	171	120	106	-730	-6.86
Net Nonoperating Obligations (NNO)	10,613	10,400	10,865	10,635	10,736	10,659	11,097	11,880	12,566	12,109	1,712
Total Depreciation and Amortization (D&A)	191	189	209	198	227	195	185	181	178	160	105
Debt-free, Cash-free Net Working Capital to Revenue	20.64%	17.81%	22.34%	19.61%	18.47%	15.76%	21.66%	24.68%	28.19%	24.20%	17.81%
Debt-free Net Working Capital to Revenue	30.10%	27.17%	30.10%	30.84%	32.33%	32.26%	34.32%	37.26%	39.88%	39.79%	118.55%
Net Working Capital to Revenue	26.06%	12.57%	14.76%	12.11%	9.53%	19.62%	21.19%	22.63%	26.00%	26.29%	108.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.19)	($17.52)	$1.06	$1.42	$1.11	$6.42	$8.73	$2.02	$0.84	$7.08	$1.76
Adjusted Weighted Average Basic Shares Outstanding	109.42M	109.27M	109.34M	109.31M	109.07M	108.85M	108.92M	108.89M	108.63M	108.38M	108.43M
Adjusted Diluted Earnings per Share	($0.19)	($17.50)	$1.06	$1.41	$1.10	$6.39	$8.69	$2.01	$0.83	$7.00	$1.75
Adjusted Weighted Average Diluted Shares Outstanding	109.42M	109.27M	109.54M	109.55M	109.51M	109.38M	109.44M	109.31M	109.19M	109.24M	109.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	109.41M	109.33M	109.31M	109.26M	109.22M	217.81M	108.86M	108.85M	108.79M	216.95M	108.43M
Normalized Net Operating Profit after Tax (NOPAT)	137	153	208	258	177	196	249	242	213	39	196
Normalized NOPAT Margin	5.74%	6.47%	7.86%	9.71%	6.78%	7.63%	9.15%	8.64%	7.48%	1.67%	8.54%
Pre Tax Income Margin	-0.13%	-64.09%	6.91%	6.90%	6.01%	5.14%	26.22%	7.73%	4.24%	-2.98%	13.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.85	-8.73	1.57	1.52	1.33	1.21	4.57	1.85	1.35	0.02	2.19
NOPAT to Interest Expense	0.58	-6.00	0.98	1.21	0.98	7.79	6.06	1.87	1.09	0.23	1.21
EBIT Less CapEx to Interest Expense	0.35	-9.37	1.05	0.92	0.51	0.49	3.86	1.05	0.50	-0.83	1.29
NOPAT Less CapEx to Interest Expense	0.08	-6.64	0.46	0.61	0.17	7.07	5.35	1.08	0.24	-0.62	0.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-16.31%	-22.46%	30.24%	17.07%	16.04%	16.09%	15.70%	24.69%	20.79%	16.30%	18.69%
Augmented Payout Ratio	-16.31%	-22.46%	30.24%	17.07%	16.04%	16.09%	15.70%	24.69%	20.79%	17.19%	31.59%

Frequently Asked Questions About Celanese's Financials

When does Celanese's financial year end?

According to the most recent income statement we have on file, Celanese's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Celanese's net income changed over the last 9 years?

Over the last 9 years, Celanese's net income changed from $285 million in 2015 to -$1.51 billion in 2024, a change of -631.2%. See Celanese's forecast for analyst expectations on what’s next for the company.

What is Celanese's operating income?

Celanese's total operating income in 2024 was -$697 million, based on the following breakdown:

Total Gross Profit: $2.36 billion
Total Operating Expenses: $3.05 billion

How has Celanese revenue changed over the last 9 years?

Over the last 9 years, Celanese's total revenue changed from $5.67 billion in 2015 to $10.28 billion in 2024, a change of 81.2%.

How much debt does Celanese have?

Celanese's total liabilities were at $17.25 billion at the end of 2024, a 9.4% decrease from 2023, and a 199.6% increase since 2015.

How much cash does Celanese have?

In the past 9 years, Celanese's cash and equivalents has ranged from $439 million in 2018 to $1.81 billion in 2023, and is currently $962 million as of their latest financial filing in 2024.

How has Celanese's book value per share changed over the last 9 years?

Over the last 9 years, Celanese's book value per share changed from 16.21 in 2015 to 47.34 in 2024, a change of 192.1%.

Related Companies

This page (NYSE:CE) was last updated on 5/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celanese (CE) Financials

Frequently Asked Questions About Celanese's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celanese (CE) Financials

Annual Income Statements for Celanese

Quarterly Income Statements for Celanese

Annual Cash Flow Statements for Celanese

Quarterly Cash Flow Statements for Celanese

Annual Balance Sheets for Celanese

Quarterly Balance Sheets for Celanese

Annual Metrics And Ratios for Celanese

Quarterly Metrics And Ratios for Celanese

Frequently Asked Questions About Celanese's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools